PIK3CA and colorectal cancer: Similarly, comparing the survival of colorectal cancer patients with PIK3CA, FBXW7 and APC mutations/CNVs to all other patients without each of these mutations, only patients with concurrent PIK3CA mutations and CNVs had poorer survival outcomes (Supplementary Figure 8, S8D–E).